Breast Surgery — MCQs

Q: A slit-shaped nipple is seen in which of the following conditions?

Duct ectasia. **Explanation:** **Duct Ectasia** is the correct answer because of the specific pathological process involving the subareolar ducts. In this condition, the major lactiferous ducts become dilated and filled with inspissated (thickened) secretions. This leads to chronic periductal inflammation, which eventually results in **fibrosis**. As this fibrosis progresses, it causes shortening of the ducts, which pulls the nipple inward. Unlike the circular "pitting" retraction seen in malignancy, the retraction in duct ectasia typically occurs in a linear fashion, resulting in a characteristic **slit-like nipple**. **Why the other options are incorrect:** * **Duct Papilloma:** This is the most common cause of bloody nipple discharge. It typically presents as a small, non-palpable lesion within a major duct and does not usually cause nipple retraction or shape changes. * **Paget’s Disease:** This presents as an eczematous, itchy, or crusting lesion of the nipple-areola complex. While it can destroy the nipple over time, it is characterized by surface erosion rather than a slit-like deformity. * **Carcinoma of the Breast:** Malignancy causes nipple retraction due to the infiltration of the **Lactiferous ducts** or **Cooper’s ligaments**. This typically results in a fixed, deep, and often asymmetrical "pitting" or "indrawing" of the nipple, rather than a transverse slit. **Clinical Pearls for NEET-PG:** * **Duct Ectasia** is also known as **Plasma Cell Mastitis** (due to the characteristic inflammatory infiltrate). * **Nipple Discharge:** In duct ectasia, the discharge is typically thick, creamy, or "toothpaste-like" (multi-colored/greenish). * **Management:** The definitive surgical treatment for duct ectasia is **Hadfield’s operation** (Total subareolar duct excision). * **Differential:** Always differentiate from **Zuska’s Disease**, which is recurrent subareolar abscesses associated with smoking and squamous metaplasia of the ducts.

Q: For which purpose is post-operative radiotherapy given in breast cancer?

To prevent recurrence. **Explanation:** The primary goal of post-operative radiotherapy (PORT) in breast cancer management is **locoregional control**. Even after a successful surgical resection (Breast Conserving Surgery or Mastectomy), microscopic foci of cancer cells may remain in the chest wall or regional lymph nodes. Radiotherapy targets these microscopic residues to **prevent local and regional recurrence**. * **Why Option C is correct:** Large clinical trials (such as the EBCTCG meta-analysis) have conclusively shown that radiotherapy significantly reduces the risk of local recurrence by approximately two-thirds. By ensuring local control, it also indirectly contributes to a modest improvement in long-term breast cancer-specific survival. * **Why Options A & D are incorrect:** Radiotherapy is a **local treatment modality**. Metastasis (distal spread to lungs, bone, or liver) is a systemic issue managed by systemic therapies like chemotherapy, hormonal therapy, or targeted therapy. While preventing local recurrence can reduce the eventual risk of seeding distant sites, the *direct* purpose of PORT is not the prevention of metastasis. * **Why Option B is incorrect:** "Ablation" usually refers to the complete destruction of a visible or known mass (e.g., radiofrequency ablation). Radiotherapy post-surgery is "adjuvant," meaning it is intended to eliminate subclinical, microscopic disease rather than ablate gross remnant tissue. **High-Yield NEET-PG Pearls:** 1. **Standard of Care:** Radiotherapy is mandatory for **all** patients undergoing Breast Conserving Surgery (BCS) to keep recurrence rates equivalent to a mastectomy. 2. **Post-Mastectomy Radiotherapy (PMRT) Indications:** Usually indicated if the tumor is >5 cm (T3), involves the skin/chest wall (T4), or if there are ≥4 positive axillary lymph nodes (N2). 3. **Timing:** If chemotherapy is indicated, radiotherapy is typically started after the completion of chemotherapy ("Sandwich regimen").

Q: Which of the following benign conditions can mimic cancer in the breast?

Fat necrosis. **Explanation:** **Fat Necrosis** is the most notorious mimic of breast carcinoma. The underlying medical concept involves the saponification of adipose tissue, usually following trauma (though trauma is only reported in 50% of cases). As the area heals by fibrosis, it forms a **hard, irregular, fixed lump** that may be associated with **skin tethering or nipple retraction**. On mammography, it can show microcalcifications or a "spiculated mass," further mimicking malignancy. Histologically, it is characterized by "foamy macrophages" and "oil cysts." **Analysis of Incorrect Options:** * **Accessory axillary breast tissue (A):** This presents as a soft, bilateral swelling in the axilla that fluctuates with hormonal changes (e.g., during menstruation or pregnancy). It lacks the hard, infiltrative features of cancer. * **Fibrocystic disease (C):** This is a spectrum of changes (cysts, fibrosis) characterized by **cyclical mastalgia** and "lumpiness." While common, it is typically diffuse and tender, unlike the painless, fixed mass of cancer. * **Granulomatous mastitis (D):** While it can present as a firm mass, it is usually associated with inflammatory signs, multiple discharging sinuses, and abscess formation, making it more likely to be confused with tuberculosis or an abscess than a primary malignancy. **High-Yield Pearls for NEET-PG:** * **Gold Standard Diagnosis:** Core Needle Biopsy is essential to differentiate fat necrosis from cancer. * **Mammographic Hallmark:** Look for **"Egg-shell calcification"** (rim calcification) in later stages of fat necrosis. * **Other Mimics:** Radial Scar (complex sclerosing lesion) and Mondor’s Disease (thrombophlebitis of superficial veins) are also important clinical mimics of breast cancer.

Q: A young female presents with a 4 cm, painless, mobile lump in her breast. What is the most likely diagnosis?

Fibroadenoma. ### Explanation **Correct Answer: C. Fibroadenoma** The clinical presentation of a **painless, firm, and highly mobile** lump in a young female is the classic description of a **Fibroadenoma**. * **Pathophysiology:** It is a benign tumor arising from the terminal duct lobular unit, characterized by an overgrowth of both glandular and stromal tissue. * **The "Breast Mouse":** Because these tumors are not fixed to the surrounding breast parenchyma or skin, they slip away under the examining fingers, earning the clinical nickname "Breast Mouse." **Why other options are incorrect:** * **A. Breast Abscess:** Typically presents with acute inflammatory signs—pain, fever, redness, and a fluctuant, tender mass. It is most common in lactating women. * **B. Breast Cyst:** While mobile, cysts are usually tense or fluctuant and often associated with cyclical mastalgia (pain) as part of fibrocystic changes. * **C. Peau d’orange:** This is a clinical sign of **Inflammatory Breast Cancer**, where the skin resembles an orange peel due to lymphatic obstruction. It indicates malignancy, not a benign mobile lump. **High-Yield Clinical Pearls for NEET-PG:** * **Most common benign tumor** of the breast in young women ( 5 cm or >500g. * **Management:** Conservative if small (<3 cm) and asymptomatic; surgical excision if increasing in size or for patient reassurance.

Q: What does the term 'tylectomy' literally mean?

Excision of a lump. **Explanation:** The term **Tylectomy** is derived from the Greek word *‘tylos’*, which means a lump, callus, or swelling, and *‘ektome’*, meaning excision. In surgical practice, it is synonymous with a **lumpectomy**. It refers to the surgical removal of a discrete breast mass along with a small margin of surrounding healthy tissue. **Analysis of Options:** * **A. Excision of a lump (Correct):** As per the etymology, tylectomy specifically refers to the removal of a palpable lump. It is a form of **Breast Conservation Surgery (BCS)**. * **B. Excision of lymph node:** This is termed a **lymphadenectomy** (e.g., Axillary Lymph Node Dissection). * **C. Excision of breast:** This is known as a **mastectomy**. Depending on the extent, it can be Simple, Modified Radical (MRM), or Radical. * **D. Excision of skin:** This is generally referred to as a **skinectomty** or wedge resection of the skin. **Clinical Pearls for NEET-PG:** * **Breast Conservation Surgery (BCS):** Includes tylectomy (lumpectomy), wide local excision, and quadrantectomy. * **Indications:** BCS is the preferred treatment for Early Breast Cancer (Stage I and II), provided the tumor-to-breast size ratio is favorable and the patient is willing to undergo mandatory postoperative radiotherapy. * **Contraindications for BCS:** Multicentric disease, prior radiation to the breast, pregnancy (absolute contraindication for radiotherapy), and persistent positive margins after re-excision. * **Triple Assessment:** Always remember the gold standard for diagnosing a breast lump: Clinical examination, Imaging (Mammography/Ultrasound), and Pathology (FNAC/Core Needle Biopsy).

Q: What is the primary investigation to diagnose stage-I carcinoma of the breast?

Bilateral mammogram. ### Explanation **1. Why Bilateral Mammogram is Correct:** In Stage-I breast carcinoma (T1N0M0), the tumor is $\leq$ 2 cm, clinically node-negative, and has no distant metastasis. **Mammography** is the gold standard for the initial diagnosis and evaluation of breast lesions. It can detect non-palpable lesions, microcalcifications (pleomorphic), and architectural distortions. A **bilateral** mammogram is essential because it allows for comparison with the contralateral breast and helps exclude multicentric or synchronous tumors in the opposite breast (found in approximately 4-5% of cases). **2. Why Other Options are Incorrect:** * **B. X-ray chest:** This is a staging investigation used to look for lung metastasis. In Stage-I disease, the risk of systemic spread is extremely low, making this unnecessary for the primary diagnosis. * **C. Bone scan:** This is used to detect skeletal metastasis. It is indicated only in symptomatic patients or those with advanced stages (Stage III/IV) and elevated alkaline phosphatase. It has no role in diagnosing early-stage (Stage-I) breast cancer. * **D. Liver scan (Ultrasound/CT):** Similar to a bone scan, this is a staging tool for distant metastasis. It is not used for primary diagnosis of the breast lesion itself. **Clinical Pearls for NEET-PG:** * **Triple Assessment:** The standard protocol for any breast lump includes: (1) Clinical Examination, (2) Imaging (Mammography if >35 years, Ultrasound if <35 years), and (3) Pathology (FNAC or Core Needle Biopsy). * **Core Needle Biopsy** is preferred over FNAC as it distinguishes between *in situ* and invasive carcinoma and allows for ER/PR/HER2/neu testing. * **Screening:** Mammography is the only screening modality proven to reduce mortality in breast cancer. * **Staging:** For Stage I and II, routine systemic imaging (CT/Bone scan) is generally **not** recommended unless the patient is symptomatic.

Q: Which of the following best describes the typical presentation of a fibroadenoma of the breast?

A solitary mobile mass. **Explanation:** **Fibroadenoma** is the most common benign tumor of the female breast, typically occurring in women aged 15–35 years. It is a biphasic tumor composed of both epithelial and stromal components. **1. Why the Correct Answer is Right:** The hallmark of a fibroadenoma is its extreme mobility within the breast tissue. Because it is a well-encapsulated lesion that does not invade the surrounding stroma, it slips away from the examining fingers. This characteristic has earned it the clinical nickname **"Breast Mouse."** It typically presents as a solitary, firm, non-tender, and well-circumscribed lump. **2. Why Incorrect Options are Wrong:** * **A. A fixed mass:** Fixity to the skin or underlying pectoral fascia is a classic sign of **malignancy** (due to infiltration) or chronic inflammatory conditions like fat necrosis. * **B & C. Diffuse masses:** Fibroadenomas are discrete, localized tumors. Diffuse or ill-defined nodularity is more characteristic of **Fibrocystic Change (Androgen and Estrogen imbalance)**, where the breast feels "lumpy-bumpy," often varying with the menstrual cycle. **High-Yield Clinical Pearls for NEET-PG:** * **Mammography:** Shows a well-defined "Popcorn calcification" in older, involuting fibroadenomas. * **USG:** Typically shows a wider-than-tall, hypoechoic, well-circumscribed lesion. * **Giant Fibroadenoma:** Defined as a fibroadenoma >5 cm in size or >500g in weight. * **Phyllodes Tumor:** The most important differential diagnosis; it grows rapidly and occurs in an older age group (40+). * **Management:** Conservative management is preferred for small, asymptomatic lesions; surgical excision is indicated if the size increases or for patient reassurance.

Breast Surgery Indian Medical PG Practice Questions and MCQs

Question 1: A patient underwent breast conservation surgery for a 3 cm lesion along with sentinel lymph node biopsy, which showed one-third of sentinel lymph nodes are positive for macrometastasis. What is the next step in management?

A. Completion axillary lymph node dissection, chemotherapy, and radiotherapy (Correct Answer)
B. Modified radical mastectomy with level I lymphadenectomy
C. Modified radical mastectomy with level III lymphadenectomy
D. Only chemotherapy and radiotherapy

Explanation: ### Explanation The management of the axilla in breast cancer depends on the size of the tumor, the extent of nodal involvement, and the planned adjuvant therapy. **Why Option A is Correct:** The patient has a **3 cm lesion (T2)** and **macrometastasis** (>2 mm) in the sentinel lymph node (SLN). According to the **ACOSOG Z0011 trial** criteria, completion Axillary Lymph Node Dissection (ALND) can be omitted *only if* the patient meets all the following: 1. T1 or T2 tumor (<5 cm). 2. <3 SLNs positive. 3. Breast Conservation Surgery (BCS) is performed. 4. **Whole-breast radiotherapy (WBRT) is planned.** While this patient meets the size and nodal count criteria, the standard of care for a positive SLN in many clinical scenarios—especially if high-risk features are suspected or if the specific Z0011 criteria are not strictly applied—remains **Completion ALND (Level I & II)** followed by systemic chemotherapy and radiotherapy to ensure regional control and guide staging. **Why Incorrect Options are Wrong:** * **Options B & C:** Modified Radical Mastectomy (MRM) is unnecessary. The patient has already undergone BCS; there is no indication to convert to a mastectomy unless margins are persistently positive or the patient cannot undergo radiation. * **Option D:** Omitting ALND ("Only chemo/RT") is currently only considered in specific Z0011-eligible patients. However, in the context of NEET-PG questions, if "Completion ALND" is an option for a macrometastasis, it remains the definitive surgical answer for axillary management. **Clinical Pearls for NEET-PG:** * **Micrometastasis:** Defined as a tumor deposit >0.2 mm but ≤2 mm. * **Macrometastasis:** Defined as a tumor deposit >2 mm. * **Z0011 Trial:** Revolutionized management by showing that ALND can be omitted in T1-T2 tumors with 1-2 positive SLNs undergoing BCS and WBRT. * **Standard ALND:** Involves removal of Level I and II nodes. Level III nodes are only removed if Level I/II are grossly involved (Berg’s Levels).

Question 2: Which of the following statements regarding breast cancer metastasis is true?

A. Metastases occur after breast cancers acquire their own new blood supply. (Correct Answer)
B. Batson's plexus facilitates metastasis to the lungs.
C. Natural killer cells have a role in breast cancer immunosurveillance.
D. Twenty percent of women who develop breast carcinoma metastases will do so within 60 months of treatment.

Explanation: ### Explanation **1. Why Option A is Correct:** The process of metastasis is highly dependent on **angiogenesis**. For a primary breast tumor to grow beyond 1–2 mm in diameter and for its cells to enter the systemic circulation (intravasation), the tumor must undergo an "angiogenic switch." By acquiring its own new blood supply, the tumor gains a route for hematogenous spread. Without neovascularization, tumor cells remain localized and nutrient-restricted. **2. Why the Other Options are Incorrect:** * **Option B:** Batson’s plexus is a valveless vertebral venous system. It facilitates metastasis to the **vertebrae, skull, and pelvic bones**, bypassing the portal and pulmonary systems. Metastasis to the lungs typically occurs via the systemic venous circulation and the heart. * **Option C:** While Natural Killer (NK) cells are vital in general immunosurveillance, current oncological consensus (and standard surgical texts like Bailey & Love) emphasizes that **T-lymphocytes** are the primary mediators of breast cancer immunosurveillance. * **Option D:** This statement is statistically inaccurate. In reality, approximately **half (50%)** of women who develop metastatic disease will do so within 60 months (5 years) of treatment. Breast cancer is notorious for late recurrences, sometimes occurring decades later. **Clinical Pearls for NEET-PG:** * **Most common site of distant metastasis:** Bone (specifically the lumbar spine due to Batson’s plexus). * **Most common visceral site of metastasis:** Lungs. * **Sentinel Lymph Node (SLN):** The first node to receive lymphatic drainage; its status is the most important prognostic factor for early breast cancer. * **Angiogenesis markers:** VEGF (Vascular Endothelial Growth Factor) is the primary driver of the new blood supply mentioned in Option A.

Question 3: A slit-shaped nipple is seen in which of the following conditions?

A. Duct ectasia (Correct Answer)
B. Duct papilloma
C. Paget's disease
D. Carcinoma of the breast

Explanation: **Explanation:** **Duct Ectasia** is the correct answer because of the specific pathological process involving the subareolar ducts. In this condition, the major lactiferous ducts become dilated and filled with inspissated (thickened) secretions. This leads to chronic periductal inflammation, which eventually results in **fibrosis**. As this fibrosis progresses, it causes shortening of the ducts, which pulls the nipple inward. Unlike the circular "pitting" retraction seen in malignancy, the retraction in duct ectasia typically occurs in a linear fashion, resulting in a characteristic **slit-like nipple**. **Why the other options are incorrect:** * **Duct Papilloma:** This is the most common cause of bloody nipple discharge. It typically presents as a small, non-palpable lesion within a major duct and does not usually cause nipple retraction or shape changes. * **Paget’s Disease:** This presents as an eczematous, itchy, or crusting lesion of the nipple-areola complex. While it can destroy the nipple over time, it is characterized by surface erosion rather than a slit-like deformity. * **Carcinoma of the Breast:** Malignancy causes nipple retraction due to the infiltration of the **Lactiferous ducts** or **Cooper’s ligaments**. This typically results in a fixed, deep, and often asymmetrical "pitting" or "indrawing" of the nipple, rather than a transverse slit. **Clinical Pearls for NEET-PG:** * **Duct Ectasia** is also known as **Plasma Cell Mastitis** (due to the characteristic inflammatory infiltrate). * **Nipple Discharge:** In duct ectasia, the discharge is typically thick, creamy, or "toothpaste-like" (multi-colored/greenish). * **Management:** The definitive surgical treatment for duct ectasia is **Hadfield’s operation** (Total subareolar duct excision). * **Differential:** Always differentiate from **Zuska’s Disease**, which is recurrent subareolar abscesses associated with smoking and squamous metaplasia of the ducts.

Question 4: For which purpose is post-operative radiotherapy given in breast cancer?

A. To prevent metastasis
B. Ablation of remnant cancer tissue
C. To prevent recurrence (Correct Answer)
D. Prevention of distal metastasis

Explanation: **Explanation:** The primary goal of post-operative radiotherapy (PORT) in breast cancer management is **locoregional control**. Even after a successful surgical resection (Breast Conserving Surgery or Mastectomy), microscopic foci of cancer cells may remain in the chest wall or regional lymph nodes. Radiotherapy targets these microscopic residues to **prevent local and regional recurrence**. * **Why Option C is correct:** Large clinical trials (such as the EBCTCG meta-analysis) have conclusively shown that radiotherapy significantly reduces the risk of local recurrence by approximately two-thirds. By ensuring local control, it also indirectly contributes to a modest improvement in long-term breast cancer-specific survival. * **Why Options A & D are incorrect:** Radiotherapy is a **local treatment modality**. Metastasis (distal spread to lungs, bone, or liver) is a systemic issue managed by systemic therapies like chemotherapy, hormonal therapy, or targeted therapy. While preventing local recurrence can reduce the eventual risk of seeding distant sites, the *direct* purpose of PORT is not the prevention of metastasis. * **Why Option B is incorrect:** "Ablation" usually refers to the complete destruction of a visible or known mass (e.g., radiofrequency ablation). Radiotherapy post-surgery is "adjuvant," meaning it is intended to eliminate subclinical, microscopic disease rather than ablate gross remnant tissue. **High-Yield NEET-PG Pearls:** 1. **Standard of Care:** Radiotherapy is mandatory for **all** patients undergoing Breast Conserving Surgery (BCS) to keep recurrence rates equivalent to a mastectomy. 2. **Post-Mastectomy Radiotherapy (PMRT) Indications:** Usually indicated if the tumor is >5 cm (T3), involves the skin/chest wall (T4), or if there are ≥4 positive axillary lymph nodes (N2). 3. **Timing:** If chemotherapy is indicated, radiotherapy is typically started after the completion of chemotherapy ("Sandwich regimen").

Question 5: Which of the following benign conditions can mimic cancer in the breast?

A. Accessory axillary breast tissue
B. Fat necrosis (Correct Answer)
C. Fibrocystic disease
D. Granulomatous mastitis

Explanation: **Explanation:** **Fat Necrosis** is the most notorious mimic of breast carcinoma. The underlying medical concept involves the saponification of adipose tissue, usually following trauma (though trauma is only reported in 50% of cases). As the area heals by fibrosis, it forms a **hard, irregular, fixed lump** that may be associated with **skin tethering or nipple retraction**. On mammography, it can show microcalcifications or a "spiculated mass," further mimicking malignancy. Histologically, it is characterized by "foamy macrophages" and "oil cysts." **Analysis of Incorrect Options:** * **Accessory axillary breast tissue (A):** This presents as a soft, bilateral swelling in the axilla that fluctuates with hormonal changes (e.g., during menstruation or pregnancy). It lacks the hard, infiltrative features of cancer. * **Fibrocystic disease (C):** This is a spectrum of changes (cysts, fibrosis) characterized by **cyclical mastalgia** and "lumpiness." While common, it is typically diffuse and tender, unlike the painless, fixed mass of cancer. * **Granulomatous mastitis (D):** While it can present as a firm mass, it is usually associated with inflammatory signs, multiple discharging sinuses, and abscess formation, making it more likely to be confused with tuberculosis or an abscess than a primary malignancy. **High-Yield Pearls for NEET-PG:** * **Gold Standard Diagnosis:** Core Needle Biopsy is essential to differentiate fat necrosis from cancer. * **Mammographic Hallmark:** Look for **"Egg-shell calcification"** (rim calcification) in later stages of fat necrosis. * **Other Mimics:** Radial Scar (complex sclerosing lesion) and Mondor’s Disease (thrombophlebitis of superficial veins) are also important clinical mimics of breast cancer.

Question 6: What surgical management is appropriate for Stage I and II breast cancer?

A. Total mastectomy
B. Modified radical mastectomy
C. Lumpectomy and axillary clearance (Correct Answer)
D. Lumpectomy, axillary clearance, and radiotherapy

Explanation: ### Explanation **Concept Overview:** Stage I and II breast cancers are classified as **Early Breast Cancer (EBC)**. The primary goal of surgical management in EBC is to achieve local control while preserving quality of life. The standard of care is **Breast Conservation Surgery (BCS)**, which consists of two essential components: local excision of the tumor (lumpectomy/wide local excision) and assessment/clearance of the axilla. **Why Option C is Correct:** In the context of surgical procedures, BCS is defined as **Lumpectomy + Axillary Clearance** (or Sentinel Lymph Node Biopsy). While radiotherapy is a mandatory *adjunct* to complete the Breast Conservation Therapy (BCT) protocol to reduce recurrence, the question specifically asks for the **surgical management**. Therefore, the surgical components are the excision of the primary mass and the axillary dissection. **Analysis of Incorrect Options:** * **Option A (Total Mastectomy):** This involves removing the entire breast tissue but excludes axillary dissection. It is insufficient for invasive Stage I/II cancer where nodal status must be addressed. * **Option B (Modified Radical Mastectomy - MRM):** While MRM is a valid treatment for Stage I/II (especially if the patient is not a candidate for BCS), modern guidelines prioritize breast conservation whenever oncologically feasible. * **Option D (Lumpectomy, Axillary Clearance, and Radiotherapy):** This describes the complete **Breast Conservation Therapy (BCT)**. However, radiotherapy is a non-surgical adjuvant treatment. In surgical exams, "surgical management" strictly refers to the operative steps. **NEET-PG High-Yield Pearls:** * **BCT vs. MRM:** Large trials (e.g., NSABP B-06) proved that BCT has the **same overall survival** as MRM for Stage I and II. * **Absolute Contraindications for BCS:** Multicentric disease, prior radiation to the breast, pregnancy (1st/2nd trimester), and persistent positive margins. * **Axillary Management:** For clinically N0 necks, **Sentinel Lymph Node Biopsy (SLNB)** is now preferred over formal axillary clearance to reduce the risk of lymphedema.

Question 7: A young female presents with a 4 cm, painless, mobile lump in her breast. What is the most likely diagnosis?

A. Breast abscess
B. Breast cyst
C. Fibroadenoma (Correct Answer)
D. Peau d'orange

Explanation: ### Explanation **Correct Answer: C. Fibroadenoma** The clinical presentation of a **painless, firm, and highly mobile** lump in a young female is the classic description of a **Fibroadenoma**. * **Pathophysiology:** It is a benign tumor arising from the terminal duct lobular unit, characterized by an overgrowth of both glandular and stromal tissue. * **The "Breast Mouse":** Because these tumors are not fixed to the surrounding breast parenchyma or skin, they slip away under the examining fingers, earning the clinical nickname "Breast Mouse." **Why other options are incorrect:** * **A. Breast Abscess:** Typically presents with acute inflammatory signs—pain, fever, redness, and a fluctuant, tender mass. It is most common in lactating women. * **B. Breast Cyst:** While mobile, cysts are usually tense or fluctuant and often associated with cyclical mastalgia (pain) as part of fibrocystic changes. * **C. Peau d’orange:** This is a clinical sign of **Inflammatory Breast Cancer**, where the skin resembles an orange peel due to lymphatic obstruction. It indicates malignancy, not a benign mobile lump. **High-Yield Clinical Pearls for NEET-PG:** * **Most common benign tumor** of the breast in young women (<30 years). * **Triple Assessment:** The gold standard for diagnosis (Clinical exam + Imaging (USG) + Pathology (FNAC/Biopsy)). * **Mammography:** Not preferred in young females due to dense breast tissue; USG is the investigation of choice. * **Giant Fibroadenoma:** Defined as a fibroadenoma >5 cm or >500g. * **Management:** Conservative if small (<3 cm) and asymptomatic; surgical excision if increasing in size or for patient reassurance.

Question 8: What does the term 'tylectomy' literally mean?

A. Excision of a lump (Correct Answer)
B. Excision of lymph node
C. Excision of breast
D. Excision of skin

Explanation: **Explanation:** The term **Tylectomy** is derived from the Greek word *‘tylos’*, which means a lump, callus, or swelling, and *‘ektome’*, meaning excision. In surgical practice, it is synonymous with a **lumpectomy**. It refers to the surgical removal of a discrete breast mass along with a small margin of surrounding healthy tissue. **Analysis of Options:** * **A. Excision of a lump (Correct):** As per the etymology, tylectomy specifically refers to the removal of a palpable lump. It is a form of **Breast Conservation Surgery (BCS)**. * **B. Excision of lymph node:** This is termed a **lymphadenectomy** (e.g., Axillary Lymph Node Dissection). * **C. Excision of breast:** This is known as a **mastectomy**. Depending on the extent, it can be Simple, Modified Radical (MRM), or Radical. * **D. Excision of skin:** This is generally referred to as a **skinectomty** or wedge resection of the skin. **Clinical Pearls for NEET-PG:** * **Breast Conservation Surgery (BCS):** Includes tylectomy (lumpectomy), wide local excision, and quadrantectomy. * **Indications:** BCS is the preferred treatment for Early Breast Cancer (Stage I and II), provided the tumor-to-breast size ratio is favorable and the patient is willing to undergo mandatory postoperative radiotherapy. * **Contraindications for BCS:** Multicentric disease, prior radiation to the breast, pregnancy (absolute contraindication for radiotherapy), and persistent positive margins after re-excision. * **Triple Assessment:** Always remember the gold standard for diagnosing a breast lump: Clinical examination, Imaging (Mammography/Ultrasound), and Pathology (FNAC/Core Needle Biopsy).

Question 9: What is the primary investigation to diagnose stage-I carcinoma of the breast?

A. Bilateral mammogram (Correct Answer)
B. X-ray chest
C. Bone scan
D. Liver scan

Explanation: ### Explanation **1. Why Bilateral Mammogram is Correct:** In Stage-I breast carcinoma (T1N0M0), the tumor is $\leq$ 2 cm, clinically node-negative, and has no distant metastasis. **Mammography** is the gold standard for the initial diagnosis and evaluation of breast lesions. It can detect non-palpable lesions, microcalcifications (pleomorphic), and architectural distortions. A **bilateral** mammogram is essential because it allows for comparison with the contralateral breast and helps exclude multicentric or synchronous tumors in the opposite breast (found in approximately 4-5% of cases). **2. Why Other Options are Incorrect:** * **B. X-ray chest:** This is a staging investigation used to look for lung metastasis. In Stage-I disease, the risk of systemic spread is extremely low, making this unnecessary for the primary diagnosis. * **C. Bone scan:** This is used to detect skeletal metastasis. It is indicated only in symptomatic patients or those with advanced stages (Stage III/IV) and elevated alkaline phosphatase. It has no role in diagnosing early-stage (Stage-I) breast cancer. * **D. Liver scan (Ultrasound/CT):** Similar to a bone scan, this is a staging tool for distant metastasis. It is not used for primary diagnosis of the breast lesion itself. **Clinical Pearls for NEET-PG:** * **Triple Assessment:** The standard protocol for any breast lump includes: (1) Clinical Examination, (2) Imaging (Mammography if >35 years, Ultrasound if <35 years), and (3) Pathology (FNAC or Core Needle Biopsy). * **Core Needle Biopsy** is preferred over FNAC as it distinguishes between *in situ* and invasive carcinoma and allows for ER/PR/HER2/neu testing. * **Screening:** Mammography is the only screening modality proven to reduce mortality in breast cancer. * **Staging:** For Stage I and II, routine systemic imaging (CT/Bone scan) is generally **not** recommended unless the patient is symptomatic.

Question 10: Which of the following best describes the typical presentation of a fibroadenoma of the breast?

A. A fixed mass
B. A diffuse mass
C. Multiple diffuse masses
D. A solitary mobile mass (Correct Answer)

Explanation: **Explanation:** **Fibroadenoma** is the most common benign tumor of the female breast, typically occurring in women aged 15–35 years. It is a biphasic tumor composed of both epithelial and stromal components. **1. Why the Correct Answer is Right:** The hallmark of a fibroadenoma is its extreme mobility within the breast tissue. Because it is a well-encapsulated lesion that does not invade the surrounding stroma, it slips away from the examining fingers. This characteristic has earned it the clinical nickname **"Breast Mouse."** It typically presents as a solitary, firm, non-tender, and well-circumscribed lump. **2. Why Incorrect Options are Wrong:** * **A. A fixed mass:** Fixity to the skin or underlying pectoral fascia is a classic sign of **malignancy** (due to infiltration) or chronic inflammatory conditions like fat necrosis. * **B & C. Diffuse masses:** Fibroadenomas are discrete, localized tumors. Diffuse or ill-defined nodularity is more characteristic of **Fibrocystic Change (Androgen and Estrogen imbalance)**, where the breast feels "lumpy-bumpy," often varying with the menstrual cycle. **High-Yield Clinical Pearls for NEET-PG:** * **Mammography:** Shows a well-defined "Popcorn calcification" in older, involuting fibroadenomas. * **USG:** Typically shows a wider-than-tall, hypoechoic, well-circumscribed lesion. * **Giant Fibroadenoma:** Defined as a fibroadenoma >5 cm in size or >500g in weight. * **Phyllodes Tumor:** The most important differential diagnosis; it grows rapidly and occurs in an older age group (40+). * **Management:** Conservative management is preferred for small, asymptomatic lesions; surgical excision is indicated if the size increases or for patient reassurance.

Practice by Chapter

Breast Anatomy and Physiology

Practice Questions

Benign Breast Diseases

Practice Questions

Breast Cancer Screening

Practice Questions

Breast Cancer: Diagnosis and Staging

Practice Questions

Surgical Management of Breast Cancer

Practice Questions

Oncoplastic Breast Surgery

Practice Questions

Sentinel Lymph Node Biopsy

Practice Questions

Axillary Surgery

Practice Questions

Breast Reconstruction Techniques

Practice Questions

Male Breast Disorders

Practice Questions

Phyllodes Tumors

Practice Questions

Management of Ductal Carcinoma In Situ

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free